Proproteins and methods of use thereof

Details for Australian Patent Application No. 2010215761 (hide)

Owner CytomX Therapeutics, Inc.

Inventors Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Sagert, Jason

Agent Cullens

Pub. Number AU-A-2010215761

PCT Pub. Number WO2010/096838

Priority 61/154,730 23.02.09 US

Filing date 23 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/04 (2006.01) Antineoplastic agents

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/096838 Priority application(s): WO2010/096838

5 April 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Sep 2011 and 21 Feb 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215769-Controller device

2010215745-Lacrimal implants and related methods